Targeting estrogen receptor signaling for treating heart failure
- PMID: 37783987
- PMCID: PMC10904494
- DOI: 10.1007/s10741-023-10356-9
Targeting estrogen receptor signaling for treating heart failure
Abstract
Heart failure (HF) is a significant public health problem worldwide. It has long been noted that premenopausal women, compared to postmenopausal women and men, have lower rates for developing this disease, as well as subsequent morbidity and mortality. This difference has been attributed to estrogen playing a cardioprotective role in these women, though exactly how it does so remains unclear. In this review, we examine the presence of estrogen receptors within the cardiovascular system, as well as the role they play behind the cardioprotective effect attributed to estrogen. Furthermore, we highlight the underlying mechanisms behind their alleviation of HF, as well as possible treatment approaches, such as hormone replacement therapy and exercise regimens, to manipulate these mechanisms in treating and preventing HF.
Keywords: Cardiac rehabilitation; Estrogen; Estrogen receptor; Heart failure; Hormone replacement therapy.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
References
-
- Bozkurt B et al (2021) Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
